Erythrosine Market By Product And Application - Global Industry Analysis And Forecast To 2023

Published On : June 2018 Pages : 190 Category: Food and Beverages Report Code : FB06970

Industry Outlook and Trend Analysis

The Erythrosine Market has encountered significant development in the recent years and is anticipated to grow tremendously over the forecast period. Colorants are significantly used to upgrade the attractiveness of the product in order to give an appealing look to the clients. Food colouring agents are majorly contributing to food & beverage industry because of rising demand for attractive and decorative food preparation among customers. Food colouring agents are broadly used in domestic and commercial food preparations. Erythrosine is a counterfeit red colouring agent derived from coal tar. Generally alluded as red dye, erythrosine is made out of iodine and sodium compounds. Erythrosine has a place with xanthene aggregate which speaks to extensive variety of splendid fluorescent colours running from yellow to bluish red. Erythrosine is generally used in food and beverage, pharmaceutical and cosmetics preparation to grant synthetic cherry-pink shading.

Drivers and Restraints

Because of expanding competitiveness, manufactures are concentrating upon food decorative products in this manner, propelling the market for erythrosine. Erythrosine is broadly used in the production of candies and cake decorative products. In addition, it assists in maintaining the flavour and nature of the product over a prolonged period of time. Thus, adding to the development of erythrosine market. Consumer’s inclination towards processed and canned food products is driving the erythrosine market.  In addition, being synthetic in nature it can be saved for longer timeframe and helps the flavour and colour to the products. Moreover, synthetic dyes as accessible at low costs when contrasted with natural dyes. Consequently, affecting the manufacturing and product cost of the erythrosine formed products. Nonetheless, most of the processed food is abundant in synthetic dye thereby, compromising upon the nutritional content of the diet. With increasing health conscious behaviour, natural dye is gaining demand among consumers hence, hampering the growth of erythrosine market.

Market Segmentation

The Erythrosine Market is segmented on the basis of form and end user. Based on form the market is segmented into granules, powder and liquid. Based on end user the market is segmented into pharmaceutical, chemical, cosmetics and food & beverages.  The food and beverages segment is leading as is foreseen to continue its domination in the market trailed by pharmaceutical.

Regional Outlook and Trend Analysis

Because of its adverse side effects on human health, erythrosine is been restricted in US by FDA. This has resulted in decline of erythrosine market in North America. Asia Pacific area represents the significant share of erythrosine market inferable from increment sought after for handled nourishment products among buyers. Europe speaks to second biggest target market for erythrosine. With expanding interest for ornamental nourishment products among customers, is driving the erythrosine market in Europe.

Competitive Insights

The leading players in the market are Dynemic Products, Univar Colour UK, KOLOR JET CHEMICAL PVT LTD, Jagson Colorchem Limited, Food Ingredient Solutions LLC, BASF, Sigma-Aldrich Inc, Parshwanath Dyestuff Industries and Sun Food Tech. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.

The Erythrosine Market is segmented as follows-

By Form:

  • Powder
  • Liquid
  • Granules

By End User:

  • Pharmaceutical
  • Food & Beverages
  • Chemical
  • Cosmetics

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Southeast Asia
    • Rest of Asia-Pacific
  • South America
    • Brazil
    • Argentina
    • Columbia
    • South Africa
    • Rest of South America
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • Nigeria
    • South Africa
    • Rest of MEA

Some of the key questions answered by the report are:

  • What was the market size in 2014 and forecast from 2015 to 2023?
  • What will be the industry market growth from 2015 to 2023?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

·         Erythrosine Market, By End User, Estimates and Forecast, 2014-2023 ($Million)

·         Food & Beverages

·         Pharmaceutical

·         Cosmetics

·         Chemical

·         Erythrosine Market, By Form, Estimates and Forecast, 2014-2023 ($Million)

·         Liquid

·         Powder

·         Granules

·         Erythrosine Market, By Region, Estimates and Forecast, 2014-2023 ($Million)

·         North America

§  North America Erythrosine Market, By Country

o    U.S. Erythrosine Market

o    Canada Erythrosine Market

o    Mexico Erythrosine Market

·         Europe

§  Europe Erythrosine Market, By Country

o    Germany Erythrosine Market

o    UK Erythrosine Market

o    France Erythrosine Market

o    Russia Erythrosine Market

o    Italy Erythrosine Market

o    Rest of Europe Erythrosine Market

·         Asia-Pacific

§  Asia-Pacific Erythrosine Market, By Country

o    China Erythrosine Market

o    Japan Erythrosine Market

o    South Korea Erythrosine Market

o    India Erythrosine Market

o    Southeast Asia Erythrosine Market

o    Rest of Asia-Pacific Erythrosine Market

·         South America

§  South America Erythrosine Market

o    Brazil Erythrosine Market

o    Argentina Erythrosine Market

o    Columbia Erythrosine Market

o    South Africa Erythrosine Market

o    Rest of South America Erythrosine Market

·         Middle East and Africa

§  Middle East and Africa Erythrosine Market

o    Saudi Arabia Erythrosine Market

o    UAE Erythrosine Market

o    Egypt Erythrosine Market

o    Nigeria Erythrosine Market

o    South Africa Erythrosine Market

o    Rest of MEA Erythrosine Market 

Table of Contents

Chapter 1. Introduction

1.1.       Report Description

1.2.       Research Methodology

1.2.1.  Secondary Research

1.2.2.  Primary Research

Chapter 2.  Executive Summary

2.1.       Key Highlights

Chapter 3. Market Overview

3.1.       Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.       Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

3.2.3.1.    Emerging Markets to Offer Lucrative Growth Opportunities

Chapter 4. Market Analysis by Regions

4.1.       North America (United States, Canada and Mexico)

4.1.1.  United States Market States and Outlook (2014-2023)

4.1.2.  Canada Market States and Outlook (2014-2023)

4.1.3.  Mexico Market States and Outlook (2014-2023)

4.2.       Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1.  Germany Market States and Outlook (2014-2023)

4.2.2.  France Market States and Outlook (2014-2023)

4.2.3.  UK Market States and Outlook (2014-2023)

4.2.4.  Russia Market States and Outlook (2014-2023)

4.2.5.  Italy Market States and Outlook (2014-2023)

4.2.6.  Rest of Europe Market States and Outlook (2014-2023)

4.3.       Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1.  China Market States and Outlook (2014-2023)

4.3.2.  Japan Market States and Outlook (2014-2023)

4.3.3.  Korea Market States and Outlook (2014-2023)

4.3.4.  India Market States and Outlook (2014-2023)

4.3.5.  Rest of Asia-Pacific Market States and Outlook (2014-2023)

4.4.       South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1.  Brazil Market States and Outlook (2014-2023)

4.4.2.  Argentina Market States and Outlook (2014-2023)

4.4.3.  Columbia Market States and Outlook (2014-2023)

4.4.4.  Rest of South America Market States and Outlook (2014-2023)

4.5.       Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1.  Saudi Arabia Market States and Outlook (2014-2023)

4.5.2.  UAE Market States and Outlook (2014-2023)

4.5.3.  Egypt Market States and Outlook (2014-2023)

4.5.4.  Nigeria Market States and Outlook (2014-2023)

4.5.5.  South Africa Market States and Outlook (2014-2023)

4.5.6.  Rest of MEA Market States and Outlook (2014-2023)

Chapter 5.Erythrosine Market, By End User

5.1.       Introduction

5.2.       Global Erythrosine Sales, Revenue and Market Share by End User (2014-2018)

5.2.1.  Global Erythrosine Sales and Sales Share by End User (2014-2018)

5.2.2.  Global Erythrosine Revenue and Revenue Share by End User (2014-2018)

5.3.       Food & Beverages

5.3.1.  Global Food & Beverages Sales and Growth Rate (2014-2018)

5.4.       Pharmaceutical

5.4.1.  Global Pharmaceutical Sales and Growth Rate (2014-2018)

5.5.       Cosmetics

5.5.1.  Global Cosmetics Sales and Growth Rate (2014-2018)

5.6.       Chemical

5.6.1.  Global Chemical Sales and Growth Rate (2014-2018)

Chapter 6. Erythrosine Market, By Form

6.1.       Introduction

6.2.       Global Erythrosine Sales, Revenue and Market Share by Form (2014-2018)

6.2.1.  Global Erythrosine Sales and Sales Share by Form (2014-2018)

6.2.2.  Global Erythrosine Revenue and Revenue Share by Form (2014-2018)

6.3.       Liquid

6.3.1.  Global Liquid Sales and Growth Rate (2014-2018)

6.4.       Powder

6.4.1.  Global Powder Sales and Growth Rate (2014-2018)

6.5.       Granules

6.5.1.  Global Granules Sales and Growth Rate (2014-2018)

Chapter 7.Erythrosine Market, By Region

7.1.       Introduction

7.2.       Global Erythrosine Sales, Revenue and Market Share by Regions

7.2.1.  Global Erythrosine Sales by Regions (2014-2018)

7.2.2.  Global Erythrosine Revenue by Regions (2014-2018)

7.3.       North America Erythrosine by Countries

7.3.1.  North America Erythrosine Sales and Growth Rate (2014-2018)

7.3.2.  North America Erythrosine Revenue and Growth Rate (2014-2018)

7.3.3.  North America Erythrosine Sales by Countries (2014-2018)

7.3.4.  North America Erythrosine Revenue (Million USD) by Countries (2014-2018)

7.3.5.  U.S.

7.3.5.1.    United States Erythrosine Sales and Growth Rate (2014-2018)

7.3.5.2.    United States Erythrosine Revenue (Millions USD) and Growth Rate (2014-2018)

7.3.6.  Canada

7.3.6.1.    Canada Erythrosine Sales and Growth Rate (2014-2018)

7.3.6.2.    Canada Erythrosine Sales (Millions USD) and Growth Rate (2014-2018)

7.3.7.  Mexico

7.3.7.1.    Mexico Erythrosine Sales and Growth Rate (2014-2018)

7.3.7.2.    Mexico Erythrosine Revenue (Millions USD) and Growth Rate (2014-2018)

7.4.       Europe Erythrosine by Countries

7.4.1.  Europe Erythrosine Sales and Growth Rate (2014-2018)

7.4.2.  Europe Erythrosine Revenue and Growth Rate (2014-2018)

7.4.3.  Europe Erythrosine Sales by Countries (2014-2018)

7.4.4.  Europe Erythrosine Revenue (Million USD) by Countries (2014-2018)

7.4.5.  Germany

7.4.5.1.    Germany Erythrosine Sales and Growth Rate (2014-2018)

7.4.5.2.    Germany Erythrosine Revenue (Millions USD) and Growth Rate (2014-2018)

7.4.6.  UK

7.4.6.1.    UK Erythrosine Sales and Growth Rate (2014-2018)

7.4.6.2.    UK Erythrosine Revenue (Millions USD) and Growth Rate (2014-2018)

7.4.7.  France

7.4.7.1.    France Erythrosine Sales and Growth Rate (2014-2018)

7.4.7.2.    France Erythrosine Revenue (Millions USD) and Growth Rate (2014-2018)

7.4.8.  Russia

7.4.8.1.    Russia Erythrosine Sales and Growth Rate (2014-2018)

7.4.8.2.    Russia Erythrosine Revenue (Millions USD) and Growth Rate (2014-2018)

7.4.9.  Italy

7.4.9.1.    Italy Erythrosine Sales and Growth Rate (2014-2018)

7.4.9.2.    Italy Erythrosine Revenue (Millions USD) and Growth Rate (2014-2018)

7.4.10.      Rest of Europe

7.4.10.1. Rest of Europe Erythrosine Sales and Growth Rate (2014-2018)

7.4.10.2. Rest of Europe Erythrosine Revenue (Millions USD) and Growth Rate (2014-2018)

7.5.       Asia-Pacific

7.5.1.  Asia-Pacific Erythrosine Sales and Growth Rate (2014-2018)

7.5.2.  Asia-Pacific Erythrosine Revenue and Growth Rate (2014-2018)

7.5.3.  Asia-Pacific Erythrosine Sales by Countries (2014-2018)

7.5.4.  Asia-Pacific Erythrosine Revenue (Million USD) by Countries (2014-2018)

7.5.5.  China

7.5.5.1.    China Erythrosine Sales and Growth Rate (2014-2018)

7.5.5.2.    China Erythrosine Revenue (Millions USD) and Growth Rate (2014-2018)

7.5.6.  Japan

7.5.6.1.    Japan Erythrosine Sales and Growth Rate (2014-2018)

7.5.6.2.    Japan Erythrosine Revenue (Millions USD) and Growth Rate (2014-2018)

7.5.6.3.     

7.5.7.  Korea

7.5.7.1.    Korea Erythrosine Sales and Growth Rate (2014-2018)

7.5.7.2.    Korea Erythrosine Revenue (Millions USD) and Growth Rate (2014-2018)

7.5.8.  India

7.5.8.1.    India Erythrosine Sales and Growth Rate (2014-2018)

7.5.8.2.    India Erythrosine Revenue (Millions USD) and Growth Rate (2014-2018)

7.5.9.  Southeast Asia

7.5.9.1.    Southeast Asia Erythrosine Sales and Growth Rate (2014-2018)

7.5.9.2.    Southeast Asia Erythrosine Revenue (Millions USD) and Growth Rate (2014-2018)

7.5.10.      Rest of Asia-Pacific

7.5.10.1. Rest of Asia-Pacific Erythrosine Sales and Growth Rate (2014-2018)

7.5.10.2. Rest of Asia-Pacific Erythrosine Revenue (Millions USD) and Growth Rate (2014-2018)

7.6.       South America

7.6.1.  South America Erythrosine Sales and Growth Rate (2014-2018)

7.6.2.  South America Erythrosine Revenue and Growth Rate (2014-2018)

7.6.3.  South America Erythrosine Sales by Countries (2014-2018)

7.6.4.  South America Erythrosine Revenue (Million USD) by Countries (2014-2018)

7.6.5.  Brazil

7.6.5.1.    Brazil Erythrosine Sales and Growth Rate (2014-2018)

7.6.5.2.    Brazil Erythrosine Revenue (Millions USD) and Growth Rate (2014-2018)

7.6.6.  Argentina

7.6.6.1.    Argentina Erythrosine Sales and Growth Rate (2014-2018)

7.6.6.2.    Argentina Erythrosine Revenue (Millions USD) and Growth Rate (2014-2018)

7.6.7.  Columbia

7.6.7.1.    Columbia Erythrosine Sales and Growth Rate (2014-2018)

7.6.7.2.    Columbia Erythrosine Revenue (Millions USD) and Growth Rate (2014-2018)

7.6.8.  Rest of South America

7.6.8.1.    Rest of South America Erythrosine Sales and Growth Rate (2014-2018)

7.6.8.2.    Rest of South America Erythrosine Revenue (Millions USD) and Growth Rate (2014-2018)

7.7.       Middle East and Africa

7.7.1.  Middle East and Africa Erythrosine Sales and Growth Rate (2014-2018)

7.7.2.  Middle East and Africa Erythrosine Revenue and Growth Rate (2014-2018)

7.7.3.  Middle East and Africa Erythrosine Sales by Countries (2014-2018)

7.7.4.  Middle East and Africa Erythrosine Revenue (Million USD) by Countries (2014-2018)

7.7.5.  Saudi Arabia

7.7.5.1.    Saudi Arabia Erythrosine Sales and Growth Rate (2014-2018)

7.7.5.2.    Saudi Arabia Erythrosine Revenue (Millions USD) and Growth Rate (2014-2018)

7.7.6.  United Arab Emirates

7.7.6.1.    United Arab Emirates Erythrosine Sales and Growth Rate (2014-2018)

7.7.6.2.    United Arab Emirates Erythrosine Revenue (Millions USD) and Growth Rate (2014-2018)

7.7.7.  Egypt

7.7.7.1.    Egypt Erythrosine Sales and Growth Rate (2014-2018)

7.7.7.2.    Egypt Erythrosine Revenue (Millions USD) and Growth Rate (2014-2018)

7.7.8.  Nigeria

7.7.8.1.    Nigeria Erythrosine Sales and Growth Rate (2014-2018)

7.7.8.2.    Nigeria Erythrosine Revenue (Millions USD) and Growth Rate (2014-2018)

7.7.9.  South Africa

7.7.9.1.    South Africa Erythrosine Sales and Growth Rate (2014-2018)

7.7.9.2.    South Africa Erythrosine Revenue (Millions USD) and Growth Rate (2014-2018)

7.7.10.      Rest of Middle East and Africa

7.7.10.1. Rest of Middle East and Africa Erythrosine Sales and Growth Rate (2014-2018)

7.7.10.2. Rest of Middle East and Africa Erythrosine Revenue (Millions USD) and Growth Rate (2014-2018)

Chapter 8.Company Profiles

8.1.       Univar Colour

8.1.1.  Business Overview

8.1.2.  Product Portfolio

8.1.3.  Strategic Developments

8.1.4.  Sales, Revenue and Market Share

8.2.       Sigma-Aldrich Co.LLC.

8.2.1.  Business Overview

8.2.2.  Product Portfolio

8.2.3.  Strategic Developments

8.2.4.  Sales, Revenue and Market Share

8.3.       Dynemic Products Ltd.

8.3.1.  Business Overview

8.3.2.  Product Portfolio

8.3.3.  Strategic Developments

8.3.4.  Sales, Revenue and Market Share

8.4.       Food Ingredient Solutions LLC

8.4.1.  Business Overview

8.4.2.  Product Portfolio

8.4.3.  Strategic Developments

8.4.4.  Sales, Revenue and Market Share

8.5.       Parshwanath Dyestuff Industries

8.5.1.  Business Overview

8.5.2.  Product Portfolio

8.5.3.  Strategic Developments

8.5.4.  Sales, Revenue and Market Share

8.6.       Sun Food Tech.

8.6.1.  Business Overview

8.6.2.  Product Portfolio

8.6.3.  Strategic Developments

8.6.4.  Sales, Revenue and Market Share

8.7.       Kolor Jet Chemical Pvt. Ltd.

8.7.1.  Business Overview

8.7.2.  Product Portfolio

8.7.3.  Strategic Developments

8.7.4.  Sales, Revenue and Market Share

8.8.       BASF SE

8.8.1.  Business Overview

8.8.2.  Product Portfolio

8.8.3.  Strategic Developments

8.8.4.  Sales, Revenue and Market Share

8.9.       Jagson Colorchem Limited

8.9.1.  Business Overview

8.9.2.  Product Portfolio

8.9.3.  Strategic Developments

8.9.4.  Sales, Revenue and Market Share

Chapter 9. Global Erythrosine Market Competition, by anufacturer

9.1.       Global Erythrosine Sales and Market Share by Manufacturer (2016-2017)

9.2.       Global Erythrosine Revenue and Market Share by Manufacturer (2016-2017)

9.3.       Global Erythrosine Price by Manufacturer (2016-2017)

9.4.       Top 5 Erythrosine Manufacturer Market Share

9.5.       Market Competition Trend

Chapter10.Erythrosine Market Forecast (2018-2023)

10.1.    Global Erythrosine Sales, Revenue (Millions USD) and Growth Rate (2018-2023)

10.2.    Erythrosine Market Forecast by Regions (2018-2023)

10.2.1.      North America Erythrosine Market Forecast (2018-2023)

10.2.1.1. United States Erythrosine Market Forecast (2018-2023)

10.2.1.2. Canada Erythrosine Market Forecast (2018-2023)

10.2.1.3. Mexico Erythrosine Market Forecast (2018-2023)

10.2.2.      Europe Erythrosine Market Forecast (2018-2023)

10.2.2.1. Germany Erythrosine Market Forecast (2018-2023)

10.2.2.2. United Kingdom Erythrosine Market Forecast (2018-2023)

10.2.2.3. France Erythrosine Market Forecast (2018-2023)

10.2.2.4. Russia Erythrosine Market Forecast (2018-2023)

10.2.2.5. Italy Erythrosine Market Forecast (2018-2023)

10.2.2.6. Rest of the Europe Erythrosine Market Forecast (2018-2023)

10.2.3.      Asia-Pacific Erythrosine Market Forecast (2018-2023)

10.2.3.1. China Erythrosine Market Forecast (2018-2023)

10.2.3.2. Japan Erythrosine Market Forecast (2018-2023)

10.2.3.3. Korea Erythrosine Market Forecast (2018-2023)

10.2.3.4. India Erythrosine Market Forecast (2018-2023)

10.2.3.5. Southeast Asia Erythrosine Market Forecast (2018-2023)

10.2.3.6. Rest of Asia-Pacific Erythrosine Market Forecast (2018-2023)

10.2.4.      South America Erythrosine Market Forecast (2018-2023)

10.2.4.1. Brazil Erythrosine Market Forecast (2018-2023)

10.2.4.2. Argentina Erythrosine Market Forecast (2018-2023)

10.2.4.3. Columbia Erythrosine Market Forecast (2018-2023)

10.2.4.4. Rest of South America Erythrosine Market Forecast (2018-2023)

10.2.5.      Middle East and Africa Erythrosine Market Forecast (2018-2023)

10.2.5.1. Saudi Arabia Erythrosine Market Forecast (2018-2023)

10.2.5.2. UAE Erythrosine Market Forecast (2018-2023)

10.2.5.3. Egypt Erythrosine Market Forecast (2018-2023)

10.2.5.4. Nigeria Erythrosine Market Forecast (2018-2023)

10.2.5.5. South Africa Erythrosine Market Forecast (2018-2023)

10.2.5.6. Rest of MEA Erythrosine Market Forecast (2018-2023)

10.3.    Erythrosine Market Forecast by End User (2018-2023)

10.3.1.      Global Erythrosine Sales Forecast by End User (2018-2023)

10.3.2.      Global Erythrosine Sales Market Share Forecast by End User (2018-2023)

10.4.    Erythrosine Market Forecast by Form (2018-2023)

10.4.1.      Global Erythrosine Sales Forecast by Form (2018-2023)

10.4.2.      Global Erythrosine Sales Market Share Forecast by Form (2018-2023)


List of Tables

(*You can glance through the list of Tables and Figures when you view the sample copy of Erythrosine Market.)


Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources

  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources

  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)

  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

License Type

For Any Assistance

*
*
*
*
*